Mario Perro in

Mario Perro

Login to view DISC.
Chief Scientific Officer at IGI
📍 Epalinges, Vaud, Switzerland

Mario Perro is the Chief Scientific Officer at IGI, leveraging over a decade of expertise in cancer immunology to develop next-generation immunotherapies. Holding a Ph. D. from University College London, he focuses on antibody-based therapeutics. Colleagues describe him as a driven, committed, and strategic expert in tumor immunology and imaging.

He is a key figure behind the development of ISB 2001, a novel trispecific T-cell engager for multiple myeloma that resulted in a major strategic partnership with Abbvie.

Read the full overview →
Experience
21 Years
Current Role
Chief Scientific Officer
Job Level
Leadership
Location
Epalinges, Vaud, Switzerland
Personality Overview

How Mario shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Mario cares about

Cancer Immunotherapy
His career at Roche and IGI has been dedicated to advancing cancer immunotherapies, including immune-checkpoint inhibitors, bispecific antibodies, and T-cell engagers.
Multiple Myeloma
His recent publications and company announcements center on developing innovative treatments like the trispecific antibody ISB 2001 for relapsed or refractory multiple myeloma.
+5 more topics Login to view topics
Career

Work history

11-2025
Chief Scientific Officer
IGI
5-2024 - 11-2025
Head of Biologics Research & Site Head, SVP
IGI
8-2021 - 5-2024
Vice-President, Head on Oncology Department
IGI
1-2021 - 8-2021
Senior Director Hematologic Malignancies, Immunotherapies
IGI
1-2017 - 1-2021
Principal Scientist, Cancer Immunotherapy, Pharmacology Department, pRED
Roche
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
2006 - 2010
Doctor of Philosophy (Ph.D.)
University College of London, PhD
2001 - 2006
110/110
Università degli Studi di Torino
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Mark Kotter
Mark Kotter
PRA (Research Professor)
University of Cambridge
 Thomas Bäck
Thomas Bäck
Chief Scientist
NORCE Norwegian Research Centre
RO
Ryan Ouellet
Director Materials Management
Sharp HealthCare
 Mehmet Nail NASIR, PhD
Mehmet Nail NASIR, PhD
Chief Scientific Officer
Astel Medica
Unlock the full playbookSee exactly how to sell to Mario. Free, 10 seconds.